🔥🔥 Don’t Miss Out on Our End of Autumn Sale. If you have any questions, feel free to click the bottom right corner to contact our customer service..

Concat us[email protected]
Shopping Cart

No products in the cart.

🔍
BS EN ISO 20031:2022

BS EN ISO 20031:2022

$189.07

Radiological protection. Monitoring and dosimetry for internal exposures due to wound contamination with radionuclides

Published By Publication Date Number of Pages
BSI 2022 48
PDF Format Searchable Printable Preview Now
Guaranteed Safe Checkout
Category:

If you have any questions, feel free to reach out to our online customer service team by clicking on the bottom right corner. We’re here to assist you 24/7.
Email:[email protected]

PDF Catalog

PDF Pages PDF Title
2 undefined
7 European foreword
Endorsement notice
8 Annex H (informative) A-deviations
11 Foreword
12 Introduction
13 1 Scope
2 Normative references
3 Terms and definitions
17 4 Symbols and abbreviated terms
4.1 Symbols
4.2 Abbreviated terms
5 Purpose and need for special monitoring programmes for internal exposures due to wound contamination with radionuclides
18 6 General aspects of wound contamination
6.1 Introduction
6.2 Category of wound contaminants
19 6.3 Types of wounds and their specific retention of radionuclides
7 Monitoring programmes to assess contamination via a wound
7.1 Introduction
7.2 Main steps for the monitoring and dosimetry for internal exposures due to wound contamination with radionuclides
20 7.3 Collection of information to characterize the contaminated wound
7.3.1 General
21 7.3.2 Information concerning the type of wound
7.3.3 Information concerning the radioactive contaminant
7.4 In vivo wound measurements
22 7.5 Systemic activity monitoring
23 8 Performance criteria for radiobioassay measurements
9 Procedure for local and systemic dose assessment
9.1 Local (wound site) dose assessment
9.2 Systemic dose assessment
25 9.3 Impact of medical intervention on dose assessment
9.3.1 Local chelation therapy and/or the excision of contaminated tissue from the wound
9.3.2 Decorporation therapy
9.4 Software tools for bioassay data interpretation
26 9.5 Uncertainties
9.5.1 General
9.5.2 Uncertainties on local dose assessment
9.5.3 Uncertainties on internal dose assessment
9.6 Quality assurance
27 10 Recording
10.1 Recording in vivo measurement results
10.2 Recording in vitro radiobioassay and treatment waste results
28 11 Documentation of the dose assessment
12 Reporting
29 Annex A (informative) Schematic representation of NCRP wound model, default parameters for retention equations and default transfer rates for the wound model for the various categories of radionuclides in wounds (adapted from NCRP report 156 (2007)[3])
32 Annex B (informative) Types of wounds and their specific retention of radionuclides
35 Annex C (informative) Example of a summary sheet that should follow the contaminated worker during his initial care
36 Annex D (informative) Overview of typical methods used for in vitro bioassay measurements
37 Annex E (informative) Equivalent dose rate in a contaminated wound (mSv·h−1·kBq−1) and equivalent dose rate received by the skin (mSv·h−1·kBq−1·cm2) for selected radionuclides
39 Annex F (informative) Committed effective dose coefficients for intake of selected radionuclides via a contaminated wound for all wound model categories (adapted from Toohey RE et al., 2014[11])
42 Annex G (informative) The IDEAS Guidelines[14] provide guidelines for the estimation of committed doses from incorporation monitoring data in case of wound
43 Bibliography

Related products

BS EN ISO 20031:2022
$189.07